Showing 441-450 of 7456 results for "".
What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.Novel Approaches to Nonmelanoma Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/novel-approaches-to-nonmelanoma-skin-cancer/23696/New and emerging treatment options are advancing care for patients with NMSC.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorSmart Mouth Approaches
https://practicaldermatology.com/conferences/asds-2021/smart-mouth-approaches/20026/When it comes to managing lines around the mouth, the best interventions may include injectables, devices, or both. Joel L. Cohen, MD discusses his favorite approaches to perioral rejuvenation.DermWireTV: COVID Vaccine Approved; Update on Delta and Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-vaccine-approved-update-on-delta-and-dermatology-practice/19998/FDA approval of Pfizer-BioNTech’s Comirnaty COVID-19 Vaccine comes as Coronavirus case rates surge across the US. We take a look at potential implications for dermatology of the Delta variant spread.A Resurgence: Ablative Resurfacing
https://practicaldermatology.com/conferences/aad-summer-2021/a-resurgence-ablative-resurfacing/19977/Mask mandates, social distancing, and increased tolerance for downtime seem to have led to an uptick in ablative resurfacing. These procedures can offer dramatic results, but Arisa Ortiz, MD says it's important to select the right patients. Plus, she offers tips for post-care counseling to manage paHair Care Trends and Treatment Advances
https://practicaldermatology.com/conferences/aad-summer-2021/hair-care-trends-and-treatment-advances/19970/Ronda S. Farah, MD shares highlights from the session she and co-panelists presented on technological advancements in the management of scalp disease. They cover the role of artificial intelligence in monitoring patients, hair cosmetic trends, lasers and platelet rich plasma in 2021, novel technologDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Scientifically Speaking: Updated Approaches to Surgical/Aesthetic Patient Safety
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-updated-approaches-to-surgicalaesthetic-patient-safety/19905/From antiseptics to eye shields, a panel of experts weighs in what you should be doing in your surgical and aesthetic practice to support patient and physician safety. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JD; Brian Biesman, MD; Suzanne Kilmer, MD; and Christopher ZachScientifically Speaking: Correcting and Avoiding Complications in Dark Skin Tones, Part 2 of 2
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-correcting-and-avoiding-complications-in-dark-skin-tones-part-2-of-2/19898/Advancements in energy-based devices mean that these tools can be used across a range of skin tones. But complications can and do still occur. In part two of a discussion on EBDs used in darker skin types, host Joel L. Cohen, MD reviews cases with Michelle Henry, MD, Omar Ibrahimi, MD, PhD, and Jenn